Neurocrine BiosciencesNBIX 
$119.85-2.01%24h
-2.01%24h
Global rank1381
Market cap$11.78B
Change 7d-0.24%
YTD Performance-7.95%
SP500 benchmarkUnderperform
P/E0
P/S6.24
Revenue$1.89B
Earnings$249.70M
Dividend yield-
Main Sector
Healthcare
Market capitalization of Neurocrine Biosciences (NBIX)
As of November 2024, Neurocrine Biosciences has a market cap of $11.78B. This makes Neurocrine Biosciences the world's 1381th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Neurocrine Biosciences from 1996 to 2024
-
Value:-
Market cap history of Neurocrine Biosciences from 1996 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $13.16B | 1.62% |
| 2023 | $12.95B | 10.31% |
| 2022 | $11.74B | 40.24% |
| 2021 | $8.37B | -11.14% |
| 2020 | $9.42B | -10.83% |
| 2019 | $10.56B | 50.53% |
| 2018 | $7.02B | -7.96% |
| 2017 | $7.62B | 100.49% |
| 2016 | $3.80B | -31.59% |
| 2015 | $5.56B | 153.22% |
| 2014 | $2.19B | 139.19% |
| 2013 | $917.67M | 24.87% |
| 2012 | $734.92M | -12.00% |
| 2011 | $835.14M | 11.26% |
| 2010 | $750.64M | 180.88% |
| 2009 | $267.25M | -15.00% |
| 2008 | $314.41M | -29.52% |
| 2007 | $446.06M | -56.43% |
| 2006 | $1.02B | -83.39% |
| 2005 | $6.16B | 27.24% |
| 2004 | $4.84B | -9.61% |
| 2003 | $5.36B | 19.45% |
| 2002 | $4.49B | -11.01% |
| 2001 | $5.04B | 54.90% |
| 2000 | $3.25B | 33.84% |
| 1999 | $2.43B | 260.00% |
| 1998 | $675.48M | -12.70% |
| 1997 | $773.73M | -21.25% |
| 1996 | $982.52M | - |
NBIX Market Cap Today is $11.78B -2.01% - 15 Nov 2024
View largest stocks by market cap 
